Transcutaneous vaccines--current and emerging strategies.
about
Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccineSize-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization.Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.Lower-Sized Chitosan Nanocapsules for Transcutaneous Antigen Delivery
P2860
Q27013822-8610F254-0B39-4D7D-90DE-F776F9B6B8A2Q33888745-1F3D85F9-F324-4156-8B90-8745ED483178Q38886698-8EA507DB-1FFE-4F31-926B-461FD5276439Q40385380-337BB841-EDAA-453A-96EF-4FEB32018AB0Q42366830-1D40E3AF-7B79-4813-B053-44EB50BDF38CQ52725104-ECF40A08-6181-415C-BF8C-3FE598EFCB32Q58701950-9EAD9B8F-77CF-4175-877A-FA9A9A631A11
P2860
Transcutaneous vaccines--current and emerging strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Transcutaneous vaccines--current and emerging strategies.
@en
type
label
Transcutaneous vaccines--current and emerging strategies.
@en
prefLabel
Transcutaneous vaccines--current and emerging strategies.
@en
P2093
P2860
P1476
Transcutaneous vaccines--current and emerging strategies.
@en
P2093
Naoki Okada
Sachiko Hirobe
Shinsaku Nakagawa
P2860
P304
P356
10.1517/17425247.2013.760542
P407
P577
2013-01-15T00:00:00Z